TNF and rheumatoid arthritis: Furthermore, biomacromolecular anti-RA agents with non-negligible increasing cost burden, such as tumor necrosis factor α (TNF-α) inhibitors, are frequently linked to infections and allergic reactions (Chen et al., 2022b; Li et al., 2023).